2011
DOI: 10.1148/radiol.10092339
|View full text |Cite
|
Sign up to set email alerts
|

Fluorocapsules for Improved Function, Immunoprotection, and Visualization of Cellular Therapeutics with MR, US, and CT Imaging

Abstract: Purpose:To develop novel immunoprotective alginate microcapsule formulations containing perfl uorocarbons (PFCs) that may increase cell function, provide immunoprotection for xenografted cells, and simultaneously enable multimodality imaging. Materials and Methods:All animal experiments were approved by an Institutional Animal Care and Use Committee. Cadaveric human islet cells were encapsulated with alginate, poly-L -lysine, and perfl uorooctyl bromide (PFOB) or perfl uoropolyether (PFPE).In vitro viability a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
75
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
1
1

Relationship

4
6

Authors

Journals

citations
Cited by 97 publications
(76 citation statements)
references
References 33 publications
1
75
0
Order By: Relevance
“…Given that clinical trials ( 18,19 ) and nonhuman primate studies (20)(21)(22)(23) of engrafted encapsulated islets have been performed, the development of a clinically applicable method that enables noninvasive monitoring of the real-time delivery, tissue engraftment, and persistence of capsule integrity is highly desirable ( 24 ). To this end, capsules labeled with barium or bismuth sulfate ( 25 ), superparamagnetic iron oxide ( 26,27 ) perfl uorocarbons ( 28 ), or a combination of superparamagnetic iron oxide and gold nanoparticles ( 29 ) have been developed that allow monitoring of engraftment with MR imaging, fl uoroscopy or computed tomography (CT), and ultrasonography (US). However, microcapsules labeled with a positive MR contrast agent are preferred for better visualization of capsules engrafted into a transplantation site that appears dark on conventional MR images, such as the liver.…”
Section: Molecular Imaging: Gadolinium-gold Microcapsule Tracking Of mentioning
confidence: 99%
“…Given that clinical trials ( 18,19 ) and nonhuman primate studies (20)(21)(22)(23) of engrafted encapsulated islets have been performed, the development of a clinically applicable method that enables noninvasive monitoring of the real-time delivery, tissue engraftment, and persistence of capsule integrity is highly desirable ( 24 ). To this end, capsules labeled with barium or bismuth sulfate ( 25 ), superparamagnetic iron oxide ( 26,27 ) perfl uorocarbons ( 28 ), or a combination of superparamagnetic iron oxide and gold nanoparticles ( 29 ) have been developed that allow monitoring of engraftment with MR imaging, fl uoroscopy or computed tomography (CT), and ultrasonography (US). However, microcapsules labeled with a positive MR contrast agent are preferred for better visualization of capsules engrafted into a transplantation site that appears dark on conventional MR images, such as the liver.…”
Section: Molecular Imaging: Gadolinium-gold Microcapsule Tracking Of mentioning
confidence: 99%
“…Placing PFC emulsions into alginate microspheres leads to spheres that are readily observed with 19 F MR imaging, US, and CT, increased in vitro insulin secretion, and enabled prolonged in vivo insulin secretion. 59,62 The strategy of incorporating contrast agents in the biomaterial may also allow for monitoring of mechanical stability in vivo. 55 Conceptually, microbead breakdown would result in dispersion of the contrast agent and altered signal intensity.…”
Section: Discussionmentioning
confidence: 99%
“…Barnett and colleagues succeeded in detecting the location of transplanted islets in an animal model, using multimodal imaging modalities (including US) and alginate microcapsule formulations containing perfluorocarbons (19); however, few such studies have been published recently.…”
Section: Discussionmentioning
confidence: 99%